Saponins as modulators of nuclear receptors

References

• Alexander, S. P., J. A. Cidlowski, E. Kelly, N. V. Marrion, J. A. Peters, E. Faccenda, S. D. Harding, A. J. Pawson, J. L. Sharman, and C. Southan. 2017. The concise guide to pharmacology 2017/18: Nuclear hormone receptors. British Journal of Pharmacology 174(S1):S208–S224.
   PubMedGoogle Scholar
• Armanini, D., S. Lewicka, C. Pratesi, M. Scali, M. C. Zennaro, S. Zovato, C. Gottardo, M. Simoncini, A. Spigariol, and V. Zampollo. 1996. Further studies on the mechanism of the mineralocorticoid action of licorice in humans. Journal of Endocrinological Investigation 19(9):624–629.
   PubMed Web of Science ®Google Scholar
• Avior, Y., D. Bomze, O. Ramon, and Y. Nahmias. 2013. Flavonoids as dietary regulators of nuclear receptor activity. Food & Function 4(6):831–844.
   PubMed Web of Science ®Google Scholar
• Bae, J.-S., H.-S. Park, J.-W. Park, S.-H. Li, and Y.-S. Chun. 2012. Red ginseng and 20(S)-Rg3 control testosterone-induced prostate hyperplasia by deregulating androgen receptor signaling. Journal of Natural Medicines 66(3):476–485.
   PubMed Web of Science ®Google Scholar
• Bahrami, Y., W. Zhang, and C. Franco. 2014. Discovery of novel saponins from the viscera of the sea cucumber holothuria lessoni. Marine Drugs 12(5):2633–2667.
   PubMed Web of Science ®Google Scholar
• Bauersachs, J., F. Jaisser, and R. Toto. 2015. Mineralocorticoid receptor activation and mineralocorticoid receptor antagonist treatment in cardiac and renal diseases. Hypertension 65(2):257–263.
   PubMed Web of Science ®Google Scholar
• Blair, R. M., H. Fang, W. S. Branham, B. S. Hass, S. L. Dial, C. L. Moland, W. Tong, L. Shi, R. Perkins, and D. M. Sheehan. 2000. The estrogen receptor relative binding affinities of 188 natural and xenochemicals: Structural diversity of ligands. Toxicological Sciences 54(1):138–153.
   PubMed Web of Science ®Google Scholar
• Bledsoe, R. K., K. P. Madauss, J. A. Holt, C. J. Apolito, M. H. Lambert, K. H. Pearce, T. B. Stanley, E. L. Stewart, R. P. Trump, T. M. Willson, et al. 2005. A ligand-mediated hydrogen bond network required for the activation of the mineralocorticoid receptor. Journal of Biological Chemistry 280(35):31283–31293.
   PubMed Web of Science ®Google Scholar
• Braissant, O., F. Foufelle, C. Scotto, M. Dauça, and W. Wahli. 1996. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-α,-β, and-γ in the adult rat. Endocrinology 137(1):354–366.
   PubMed Web of Science ®Google Scholar
• Brzozowski, A. M., A. C. Pike, Z. Dauter, R. E. Hubbard, T. Bonn, O. Engström, L. Ohman, G. L. Greene, J. A. Gustafsson, M. Carlquist, et al. 1997. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389(6652):753–758.
   PubMed Web of Science ®Google Scholar
• Caiozzi, G., B. S. Wong, and M.-L. Ricketts. 2012. Dietary modification of metabolic pathways via nuclear hormone receptors. Cell Biochemistry and Function 30(7):531–551.
   PubMed Web of Science ®Google Scholar
• Casanova, M., L. You, K. W. Gaido, S. Archibeque-Engle, D. B. Janszen, and H. A. Heck. 1999. Developmental effects of dietary phytoestrogens in spraque-dawley rats and interactions of genistein and daidzein with rat estrogen receptor α and β in vitro. Toxicological Sciences 51(2):236–244.
   PubMed Web of Science ®Google Scholar
• Chavez-Santoscoy, R. A., J. A. Gutierrez-Uribe, O. Granados, I. Torre-Villalvazo, S. O. Serna-Saldivar, N. Torres, B. Palacios-González, and A. R. Tovar. 2014. Flavonoids and saponins extracted from black bean (Phaseolus vulgaris L.) seed coats modulate lipid metabolism and biliary cholesterol secretion in C57BL/6 mice. British Journal of Nutrition 112(06):886–899.
   PubMedGoogle Scholar
• Chawla, A., J. J. Repa, R. M. Evans, and D. J. Mangelsdorf. 2001. Nuclear receptors and lipid physiology: Opening the X-files. Science 294(5548):1866–1870.
   PubMed Web of Science ®Google Scholar
• Cheung, L. W. T., K. W. Leung, C. K. C. Wong, R. N. S. Wong, and A. S. T. Wong. 2011. Ginsenoside-Rg1 induces angiogenesis via non-genomic crosstalk of glucocorticoid receptor and fibroblast growth factor receptor-1. Cardiovascular Research 89(2):419–425.
   PubMed Web of Science ®Google Scholar
• Cho, J., W. Park, S. Lee, W. Ahn, and Y. Lee. 2004. Ginsenoside-Rb1 from panax ginseng C.A. Meyer activates estrogen receptor-α and -β, independent of ligand binding. The Journal of Clinical Endocrinology and Metabolism 89(7):3510–3515.
   PubMed Web of Science ®Google Scholar
• Coumoul, X., M. Diry, and R. Barouki. 2002. PXR-dependent induction of human CYP3A4 gene expression by organochlorine pesticides. Biochemical Pharmacology 64(10):1513–1519.
   PubMed Web of Science ®Google Scholar
• Couse, J. F., J. Lindzey, K. Grandien, J.-A. K. Gustafsson, and K. S. Korach. 1997. Tissue distribution and quantitative analysis of estrogen receptor-α (ERα) and estrogen receptor-β (ERβ) messenger ribonucleic acid in the wild-type and ERα-knockout mouse. Endocrinology 138(11):4613–4621.
   PubMed Web of Science ®Google Scholar
• Del Bas, J. M., M.-L. Ricketts, M. Vaqué, E. Sala, H. Quesada, A. Ardevol, M. J. Salvadó, M. Blay, L. Arola, D. D. Moore, et al. 2009. Dietary procyanidins enhance transcriptional activity of bile acid-activated FXR in vitro and reduce triglyceridemia in vivo in a FXR-dependent manner. Molecular Nutrition & Food Research 53(7):805–814.
   PubMed Web of Science ®Google Scholar
• Delfosse, V., B. Dendele, T. Huet, M. Grimaldi, A. Boulahtouf, S. Gerbal-Chaloin, B. Beucher, D. Roecklin, C. Muller, R. Rahmani, et al. 2015. Synergistic activation of human pregnane X receptor by binary cocktails of pharmaceutical and environmental compounds. Nature Communications 6(1):8089.
   PubMedGoogle Scholar
• Deroo, B. J., and K. S. Korach. 2006. Estrogen receptors and human disease. Journal of Clinical Investigation 116(3):561–570.
   PubMed Web of Science ®Google Scholar
• Ding, L., L. Yang, Z. Wang, and W. Huang. 2015. Bile acid nuclear receptor FXR and digestive system diseases. Acta Pharmaceutica Sinica B 5(2):135–144.
   PubMed Web of Science ®Google Scholar
• Duma, D., C. M. Jewell, and J. A. Cidlowski. 2006. Multiple glucocorticoid receptor isoforms and mechanisms of post-translational modification. The Journal of Steroid Biochemistry and Molecular Biology 102(1–5):11–21.
   PubMed Web of Science ®Google Scholar
• Edman, K., A. Hosseini, M. K. Bjursell, A. Aagaard, L. Wissler, A. Gunnarsson, T. Kaminski, C. Köhler, S. Bäckström, T. J. Jensen, et al. 2015. Ligand binding mechanism in steroid receptors: From conserved plasticity to differential evolutionary constraints. Structure 23(12):2280–2290.
   PubMed Web of Science ®Google Scholar
• Ehrman, D. A., R. B. Barnes, and R. L. Rosenfield. 1995. Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocrine Reviews 16(3):322–353.
   PubMed Web of Science ®Google Scholar
• Eloranta, J. J., and G. A. Kullak-Ublick. 2008. The role of FXR in disorders of bile acid homeostasis. Physiology 23:286–295.
   PubMed Web of Science ®Google Scholar
• Fan, J.-S., D.-N. Liu, G. Huang, Z.-Z. Xu, Y. Jia, H.-G. Zhang, X.-H. Li, and F.-T. He. 2012. Panax notoginseng saponins attenuate atherosclerosis via reciprocal regulation of lipid metabolism and inflammation by inducing liver X receptor α expression. Journal of Ethnopharmacology 142(3):732–738.
   PubMed Web of Science ®Google Scholar
• Farooq, A. 2015. Structural and functional diversity of estrogen receptor ligands. Current Topics in Medicinal Chemistry 15(14):1372–1384.
   PubMed Web of Science ®Google Scholar
• Feng, Q., and B. W. O’Malley. 2014. Nuclear receptor modulation–Role of coregulators in selective estrogen receptor modulator (SERM) actions. Steroids 90:39–43.
   PubMed Web of Science ®Google Scholar
• Forman, B. M., E. Goode, J. Chen, A. E. Oro, D. J. Bradley, T. Perlmann, D. J. Noonan, L. T. Burka, T. McMorris, W. W. Lamph, et al. 1995. Identification of a nuclear receptor that is activated by farnesol metabolites. Cell 81(5):687–693.
   PubMed Web of Science ®Google Scholar
• Francis, G. A., E. Fayard, F. Picard, and J. Auwerx. 2003. Nuclear receptors and the control of metabolism. Annual Review of Physiology 65:261–311.
   PubMed Web of Science ®Google Scholar
• Francis, G., Z. Kerem, H. P. S. Makkar, and K. Becker. 2002. The biological action of saponins in animal systems: a review. The British Journal of Nutrition 88(6):587–605.
   PubMed Web of Science ®Google Scholar
• Fuller, P. J. 2015. Novel interactions of the mineralocorticoid receptor. Molecular and Cellular Endocrinology 408:33–7.
   PubMed Web of Science ®Google Scholar
• Gadaleta, R. M., K. J. van Erpecum, B. Oldenburg, E. C. L. Willemsen, W. Renooij, S. Murzilli, L. W. J. Klomp, P. D. Siersema, M. E. I. Schipper, S. Danese, et al. 2011. Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease. Gut 60(4):463–472.
   PubMed Web of Science ®Google Scholar
• Gao, W., C. E. Bohl, and J. T. Dalton. 2005. Chemistry and structural biology of androgen receptor. Chemical Reviews 105(9):3352–3370.
   PubMed Web of Science ®Google Scholar
• Gao, Y., M.-F. Yang, Y.-P. Su, H.-M. Jiang, X.-J. You, Y.-J. Yang, and H.-L. Zhang. 2013. Ginsenoside re reduces insulin resistance through activation of PPAR-γ pathway and inhibition of TNF-α production. Journal of Ethnopharmacology 147(2):509–516.
   PubMed Web of Science ®Google Scholar
• Gao, Y., S. Chu, J. Li, J. Li, Z. Zhang, C. Xia, Y. Heng, M. Zhang, J. Hu, G. Wei., et al. 2015. Anti-inflammatory function of ginsenoside Rg1 on alcoholic hepatitis through glucocorticoid receptor related nuclear factor-kappa B pathway. Journal of Ethnopharmacology 173:231–240.
   PubMed Web of Science ®Google Scholar
• Gauthaman, K., and P. G. Adaikan. 2005. Effect of tribulus terrestris on nicotinamide adenine dinucleotide phosphate-diaphorase activity and androgen receptors in rat brain. Journal of Ethnopharmacology 96(1–2):127–132.
   PubMed Web of Science ®Google Scholar
• Gelmann, E. P. 2002. Molecular biology of the androgen receptor. Journal of Clinical Oncology 20(13):3001–3015.
   PubMed Web of Science ®Google Scholar
• Geyeregger, R., M. Zeyda, and T. M. Stulnig. 2006. Liver X receptors in cardiovascular and metabolic disease. Cellular and Molecular Life Sciences 63(5):524–539.
   PubMed Web of Science ®Google Scholar
• Gopisetty Venkata, N., J. A. Robinson, P. J. Cabot, B. Davis, G. R. Monteith, and S. J. Roberts-Thomson. 2006. Mono(2-ethylhexyl)phthalate and mono-n-butyl phthalate activation of peroxisome proliferator activated-receptors α and γ in breast. Toxicology Letters 163(3):224–234.
   PubMed Web of Science ®Google Scholar
• Gu, M., T. M. Kortner, M. Penn, A. K. Hansen, and Å. Krogdahl. 2014. Effects of dietary plant meal and soya-saponin supplementation on intestinal and hepatic lipid droplet accumulation and lipoprotein and sterol metabolism in atlantic salmon (salmo salar L.). British Journal of Nutrition 111(03):432–444.
   PubMedGoogle Scholar
• Güçlü-Ustündağ, O., and G. Mazza. 2007. Saponins: Properties, applications and processing. Critical Reviews in Food Science and Nutrition 47(3):231–258.
   PubMed Web of Science ®Google Scholar
• Gustafsson, J.-A. 2016. Historical overview of nuclear receptors. The Journal of Steroid Biochemistry and Molecular Biology 157:3–6.
   PubMed Web of Science ®Google Scholar
• Hasmall, S. C., N. H. James, N. Macdonald, A. R. Soames, and R. A. Roberts. 2000. Species differences in response to diethylhexylphthalate: Suppression of apoptosis, induction of DNA synthesis and peroxisome proliferator activated receptor alpha-mediated gene expression. Archives of Toxicology 74(2):85–91.
   PubMed Web of Science ®Google Scholar
• Heinlein, C. A., and C. Chang. 2004. Androgen receptor in prostate cancer. Endocrine Reviews 25(2):276–308.
   PubMed Web of Science ®Google Scholar
• Huang, T. H.-W., V. H. Tran, B. D. Roufogalis, and Y. Li. 2007. Gypenoside XLIX, a naturally occurring PPAR-α activator, inhibits cytokine-induced vascular cell adhesion molecule-1 expression and activity in human endothelial cells. European Journal of Pharmacology 565(1–3):158–165.
   PubMed Web of Science ®Google Scholar
• Huang, T. H.-W., V. Razmovski-Naumovski, N. K. Salam, R. K. Duke, V. H. Tran, C. C. Duke, and B. D. Roufogalis. 2005. A novel LXR-α activator identified from the natural product gynostemma pentaphyllum. Biochemical Pharmacology 70(9):1298–1308.
   PubMed Web of Science ®Google Scholar
• Hwang, Y. P., J. H. Choi, H. G. Kim, T. Khanal, G. Y. Song, M. S. Nam, H.-S. Lee, Y. C. Chung, Y. C. Lee, and H. G. Jeong. 2013. Saponins, especially platycodin D, from platycodon grandiflorum modulate hepatic lipogenesis in high-fat diet-fed rats and high glucose-exposed HepG2 cells. Toxicology and Applied Pharmacology 267(2):174–183.
   PubMed Web of Science ®Google Scholar
• Itoh, T., L. Fairall, K. Amin, Y. Inaba, A. Szanto, B. L. Balint, L. Nagy, K. Yamamoto, and J. W. R. Schwabe. 2008. Structural basis for the activation of PPARgamma by oxidized fatty acids. Nature Structural & Molecular Biology 15(9):924–931.
   PubMed Web of Science ®Google Scholar
• Jalsrai, A., T. Numakawa, H. Kunugi, D. C. Dieterich, and A. Becker. 2016. The neuroprotective effects and possible mechanism of action of a methanol extract from asparagus cochinchinensis: In vitro and in vivo studies. Neuroscience 322:452–463. (03):
   PubMed Web of Science ®Google Scholar
• Janowski, B. A., M. J. Grogan, S. A. Jones, G. B. Wisely, S. A. Kliewer, E. J. Corey, and D. J. Mangelsdorf. 1999. Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbeta. Proceedings of the National Academy of Sciences of the United States of America 96(1):266–271.
   PubMed Web of Science ®Google Scholar
• Jin, L., and Y. Li. 2010. Structural and functional insights into nuclear receptor signaling. Advanced Drug Delivery Reviews 62(13):1218–1226.
   PubMed Web of Science ®Google Scholar
• Kageyama, Y., H. Suzuki, and T. Saruta. 1992. Glycyrrhizin induces mineralocorticoid activity through alterations in cortisol metabolism in the human kidney. Journal of Endocrinology 135(1):147–152.
   PubMed Web of Science ®Google Scholar
• Kersten, S., B. Desvergne, and W. Wahli. 2000. Roles of PPARs in health and disease. Nature 405(6785):421–424.
   PubMed Web of Science ®Google Scholar
• Kim, J. H., and Y. N. Han. 2011. Dammarane-type saponins from gynostemma pentaphyllum. Phytochemistry 72(11–12):1453–1459.
   PubMed Web of Science ®Google Scholar
• Krasowski, M. D., A. Ni, L. R. Hagey, and S. Ekins. 2011. Evolution of promiscuous nuclear hormone receptors: LXR, FXR, VDR, PXR, and CAR. Molecular and Cellular Endocrinology 334(1–2):39–48.
   PubMed Web of Science ®Google Scholar
• Kuiper, G. G. J. M., B. Carlsson, K. Grandien, E. Enmark, J. Häggblad, S. Nilsson, and J.-Å. Gustafsson. 1997. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology 138(3):863–870.
   PubMed Web of Science ®Google Scholar
• Ky, P. T., P. T. Huong, T. K. My, P. T. Anh, P. V. Kiem, C. Van Minh, N. X. Cuong, N. P. Thao, N. X. Nhiem, J.-H. Hyun, et al. 2010. Dammarane-type saponins from gynostemma pentaphyllum. Phytochemistry 71(8–9):994–1001.
   PubMed Web of Science ®Google Scholar
• Lee, Y. J., Y. R. Jin, W. C. Lim, S. M. Ji, S. Choi, S. Jang, and S. K. Lee. 2003. A ginsenoside-Rh1, a component of ginseng saponin, activates estrogen receptor in human breast carcinoma MCF-7 cells. The Journal of Steroid Biochemistry and Molecular Biology 84(4):463–468.
   PubMed Web of Science ®Google Scholar
• Leung, K. W., F. P. Leung, Y. Huang, N. K. Mak, and R. N. S. Wong. 2007. Non-genomic effects of ginsenoside-Re in endothelial cells via glucocorticoid receptor. FEBS Letters 581(13):2423–2428.
   PubMed Web of Science ®Google Scholar
• Li, L., F. Bonneton, X. Y. Chen, and V. Laudet. 2015. Botanical compounds and their regulation of nuclear receptor action: The case of traditional Chinese medicine. Molecular and Cellular Endocrinology 401:221–237.
   PubMed Web of Science ®Google Scholar
• Li, W., X. T. Yan, Y. N. Sun, T. T. Ngan, S. H. Shim, and Y. H. Kim. 2014. Anti-inflammatory and PPAR transactivational effects of oleanane-type triterpenoid saponins from the roots of pulsatilla koreana. Biomolecules & Therapeutics 22(4):334–340.
   PubMed Web of Science ®Google Scholar
• Liang, X-P, D-Q Zhang, Y-y Chen, R. Guo, J. Wang, C-Z Wang, and Y-h Shi. 2015. Effects of alfalfa saponin extract on mRNA expression of ldlr, LXRα, and FXR in BRL cells. Journal of Zhejiang University Science B 16(6):479–486.
   PubMed Web of Science ®Google Scholar
• Liu, H.-S., H.-L. Shi, F. Huang, K. E. Peterson, H. Wu, Y.-Y. Lan, B.-B. Zhang, Y.-X. He, T. Woods, M. Du, et al. 2016. Astragaloside IV inhibits microglia activation via glucocorticoid receptor mediated signaling pathway. Scientific Reports 6(1):19137.
   PubMedGoogle Scholar
• Liu, J., Jiang, C., Ma, X. and Wang, J. 2018. Notoginsenoside Fc attenuates high glucose-induced vascular endothelial cell injury via upregulation of PPAR-γ in diabetic Sprague-Dawley rats. Vascular Pharmacology 109:27–35. DOI:10.1016/j.vph.2018.05.009.
   PubMed Web of Science ®Google Scholar
• Liu, W. K., S. X. Xu, and C. T. Che. 2000. Anti-proliferative effect of ginseng saponins on human prostate cancer cell line. Life Sciences 67(11):1297–1306.
   PubMed Web of Science ®Google Scholar
• Lu, J.-M., Y.-F. Wang, H.-L. Yan, P. Lin, W. Gu, and J. Yu. 2016. Antidiabetic effect of total saponins from polygonatum kingianum in streptozotocin-induced daibetic rats. Journal of Ethnopharmacology 179:291–300.
   PubMed Web of Science ®Google Scholar
• Makishima, M., A. Y. Okamoto, J. J. Repa, H. Tu, R. M. Learned, A. Luk, M. V. Hull, K. D. Lustig, D. J. Mangelsdorf, B. Shan, et al. 1999. Identification of a nuclear receptor for bile acids. Science 284(5418):1362–1365.
   PubMed Web of Science ®Google Scholar
• Manda, V. K., O. R. Dale, C. Awortwe, Z. Ali, I. A. Khan, L. A. Walker, and S. I. Khan. 2014. Evaluation of drug interaction potential of Labisia pumila (kacip fatimah) and its constituents. Frontiers in Pharmacology 5:178. (
   PubMed Web of Science ®Google Scholar
• Matsumoto, T., M. Sakari, M. Okada, A. Yokoyama, S. Takahashi, A. Kouzmenko, and S. Kato. 2013. The androgen receptor in health and disease. Annual Review of Physiology 75(1):201–224.
   PubMedGoogle Scholar
• Mi, L.-Z., S. Devarakonda, J. M. Harp, Q. Han, R. Pellicciari, T. M. Willson, S. Khorasanizadeh, and F. Rastinejad. 2003. Structural basis for bile acid binding and activation of the nuclear receptor FXR. Molecular Cell 11(4):1093–1100.
   PubMed Web of Science ®Google Scholar
• Moore, J. T., L. B. Moore, J. M. Maglich, and S. A. Kliewer. 2003. Functional and structural comparison of PXR and CAR. Biochimica et Biophysica Acta 1619(3):235–238.
   PubMed Web of Science ®Google Scholar
• Moore, L. B., D. J. Parks, S. A. Jones, R. K. Bledsoe, T. G. Consler, J. B. Stimmel, B. Goodwin, C. Liddle, S. G. Blanchard, T. M. Willson, et al. 2000. Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands. Journal of Biological Chemistry 275(20):15122–15127.
   PubMed Web of Science ®Google Scholar
• Moore, L. B., J. M. Maglich, D. D. McKee, B. Wisely, T. M. Willson, S. A. Kliewer, M. H. Lambert, and J. T. Moore. 2002. Pregnane X receptor (PXR), constitutive androstane receptor (CAR), and benzoate X receptor (BXR) define three pharmacologically distinct classes of nuclear receptors. Molecular Endocrinology 16(5):977–986.
   PubMed Web of Science ®Google Scholar
• Mueller, K. B.., S. B. Bender, K. Hong, Y. Yang, M. Aronovitz, F. Jaisser, M. A. Hill, and I. Z. Jaffe. 2015. Endothelial mineralocorticoid receptors differentially contribute to coronary and mesenteric vascular function without modulating blood pressure. Hypertension 66(5):988–997.
   PubMed Web of Science ®Google Scholar
• Nagy, L., P. Tontonoz, J. G. Alvarez, H. Chen, and R. M. Evans. 1998. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. Cell 93(2):229–240.
   PubMed Web of Science ®Google Scholar
• Overington, J. P., B. Al-Lazikani, and A. L. Hopkins. 2006. How many drug targets are there? Nature Reviews Drug Discovery 5(12):993–996.
   PubMed Web of Science ®Google Scholar
• Parks, D. J., S. G. Blanchard, R. K. Bledsoe, G. Chandra, T. G. Consler, S. A. Kliewer., J.B. Stimmel, T. M. Willson, A. M. Zavacki, D. D. Moore, et al. 1999. Bile acids: Natural ligands for an orphan nuclear receptor. Science 284(5418):1365–1368.
   PubMed Web of Science ®Google Scholar
• Pearce, K. H., M. A. Iannone, C. A. Simmons, and J. G. Gray. 2004. Discovery of novel nuclear receptor modulating ligands: An integral role for peptide interaction profiling. Drug Discovery Today 9(17):741–751.
   PubMed Web of Science ®Google Scholar
• Pereira de Jésus-Tran, K., P.-L. Côté, L. Cantin, J. Blanchet, F. Labrie, and R. Breton. 2006. Comparison of crystal structures of human androgen receptor ligand-binding domain complexed with various agonists reveals molecular determinants responsible for binding affinity. Protein Science 15(5):987–999.
   PubMed Web of Science ®Google Scholar
• Qi, L.-W., C.-Z. Wang, and C.-S. Yuan. 2010. American ginseng: Potential structure–function relationship in cancer chemoprevention. Biochemical Pharmacology 80(7):947–954.
   PubMed Web of Science ®Google Scholar
• Qiu, J. 2007. Traditional medicine: a culture in the balance. Nature 448(7150):126–128.
   PubMed Web of Science ®Google Scholar
• Quang, T. H., N. T. T. Ngan, C. V. Minh, P. V. Kiem, N. P. Thao, B. H. Tai, N. X. Nhiem, S. B. Song, and Y. H. Kim. 2011. Effect of triterpenes and triterpene saponins from the stem bark of kalopanax pictus on the transactivational activities of three PPAR subtypes. Carbohydrate Research 346(16):2567–2575.
   PubMed Web of Science ®Google Scholar
• Ramanathan, M. R., and S. R. Penzak. 2017. Pharmacokinetic drug interactions with panax ginseng. European Journal of Drug Metabolism and Pharmacokinetics 42(4):545–557.
   PubMed Web of Science ®Google Scholar
• Roberts, R. A. 1999. Peroxisome proliferators: Mechanisms of adverse effects in rodents and molecular basis for species differences. Archives of Toxicology 73(8–9):413–418.
   PubMed Web of Science ®Google Scholar
• Routledge, E. J., R. White, M. G. Parker, and J. P. Sumpter. 2000. Differential effects of xenoestrogens on coactivator recruitment by estrogen receptor (ER) α and ERβ. Journal of Biological Chemistry 275(46):35986–35993.
   PubMed Web of Science ®Google Scholar
• Shang, W., Y. Yang, B. Jiang, H. Jin, L. Zhou, S. Liu, and M. Chen. 2007. Ginsenoside Rb1 promotes adipogenesis in 3T3-L1 cells by enhancing PPARgamma2 and C/EBPalpha gene expression . Life Sciences 80(7):618–625.
   PubMed Web of Science ®Google Scholar
• Shen, K., S. W. S. Leung, L. Ji, Y. Huang, M. Hou, A. Xu, Z. Wang, and P. M. Vanhoutte. 2014. Notoginsenoside Ft1 activates both glucocorticoid and estrogen receptors to induce endothelium-dependent, nitric oxide-mediated relaxations in rat mesenteric arteries. Biochemical Pharmacology 88(1):66–74.
   PubMed Web of Science ®Google Scholar
• Shen, Q., D. Zeng, Y. Zhou, L. Xia, Y. Zhao, G. Qiao, L. Xu, Y. Liu, Z. Zhu, X. Jiang, et al. 2013. Curculigoside promotes osteogenic differentiation of bone marrow stromal cells from ovariectomized rats. Journal of Pharmacy and Pharmacology 65(7):1005–1013.
   PubMed Web of Science ®Google Scholar
• Shen, S. S., C. L. Smith, J.-T. Hsieh, J. Yu, I. Y. Kim, W. Jian, G. Sonpavde, G. E. Ayala, M. Younes, S. P. Lerner, et al. 2006. Expression of estrogen receptors-α and -β in bladder cancer cell lines and human bladder tumor tissue. Cancer 106(12):2610–2616.
   PubMed Web of Science ®Google Scholar
• Shi, C., D-D Zheng, L. Fang, F. Wu, W. H. Kwong, and J. Xu. 2012. Ginsenoside Rg1 promotes nonamyloidgenic cleavage of APP via estrogen receptor signaling to MAPK/ERK and PI3K/akt. BBA-General Subjects 1820(4):453–460.
   PubMed Web of Science ®Google Scholar
• Siddiqi, M. H., M. Z. Siddiqi, S. Ahn, S. Kang, Y.-J. Kim, N. Sathishkumar, D.-U. Yang, and D.-C. Yang. 2013. Ginseng saponins and the treatment of osteoporosis: mini literature review. Journal of Ginseng Research 37(3):261–268.
   PubMed Web of Science ®Google Scholar
• Simons, R., H. Gruppen, T. F. H. Bovee, M. A. Verbruggen, and J.-P. Vincken. 2012. Prenylated isoflavonoids from plants as selective estrogen receptor modulators (phytoSERMs). Food & Function 3(8):810–827.
   PubMed Web of Science ®Google Scholar
• Singh, B., J. P. Singh, N. Singh, and A. Kaur. 2017. Saponins in pulses and their health promoting activities: A review. Food Chemistry 233:540–549.
   PubMed Web of Science ®Google Scholar
• Siraj, F. M., N. SathishKumar, Y. J. Kim, S. Y. Kim, and D. C. Yang. 2015. Ginsenoside F2 possesses anti-obesity activity via binding with PPARγ and inhibiting adipocyte differentiation in the 3T3-L1 cell line. Journal of Enzyme Inhibition and Medicinal Chemistry 30(1):9–14.
   PubMed Web of Science ®Google Scholar
• Siraj, F. M., S. Natarajan, M. A. Huq, Y. J. Kim, and D. C. Yang. 2015. Structural investigation of ginsenoside Rf with PPARγ major transcriptional factor of adipogenesis and its impact on adipocyte. Journal of Ginseng Research 39(2):141–147.
   PubMed Web of Science ®Google Scholar
• Smith, C. L., and B. W. O’Malley. 2004. Coregulator function: A key to understanding tissue specificity of selective receptor modulators. Endocrine Reviews 25(1):45–71.
   PubMed Web of Science ®Google Scholar
• Sparg, S. G., M. E. Light, and J. van Staden. 2004. Biological activities and distribution of plant saponins. Journal of Ethnopharmacology 94(2–3):219–243.
   PubMed Web of Science ®Google Scholar
• Staudinger, J. L., X. Ding, and K. Lichti. 2006. Pregnane X receptor and natural products: Beyond drug-drug interactions. Expert Opinion on Drug Metabolism & Toxicology 2(6):847–857.
   PubMed Web of Science ®Google Scholar
• Sun, B., J. Xiao, X.-B. Sun, and Y. Wu. 2013. Notoginsenoside R1 attenuates cardiac dysfunction in endotoxemic mice: An insight into oestrogen receptor activation and PI3K/akt signalling. British Journal of Pharmacology 168(7):1758–1770.
   PubMed Web of Science ®Google Scholar
• Tanaka, T., J. Yamamoto, S. Iwasaki, H. Asaba, H. Hamura, Y. Ikeda, M. Watanabe, K. Magoori, R. X. Ioka, K. Tachibana, et al. 2003. Activation of peroxisome proliferator-activated receptor δ induces fatty acid β-oxidation in skeletal muscle and attenuates metabolic syndrome. Proceedings of the National Academy of Sciences of the United States of America 100(26):15924–15929.
   PubMed Web of Science ®Google Scholar
• Taplin, M.-E. 2007. Drug insight: Role of the androgen receptor in the development and progression of prostate cancer. Nature Clinical Practice Oncology 4(4):236–244.
   PubMedGoogle Scholar
• Tarjus, A., C. Amador, L. Michea, and F. Jaisser. 2015. Vascular mineralocorticoid receptor and blood pressure regulation. Current Opinion in Pharmacology 21:138–144.
   PubMed Web of Science ®Google Scholar
• Tohma, H. S., and I. Gulçin. 2010. Antioxidant and radical scavenging activity of aerial parts and roots of turkish liquorice (glycyrrhiza glabra L.). International Journal of Food Properties 13(4):657–671.
   Web of Science ®Google Scholar
• Turner, A. B., D. S. Smith, and A. M. Mackie. 1971. Characterization of the principal steroidal saponins of the starfish marthasterias glacialis: structures of the aglycones. Nature 233(5316):209–210.
   PubMed Web of Science ®Google Scholar
• Turner, J. D., A. B. Schote, J. A. Macedo, L. P. L. Pelascini, and C. P. Muller. 2006. Tissue specific glucocorticoid receptor expression, a role for alternative first exon usage? Biochemical Pharmacology 72(11):1529–1537.
   PubMed Web of Science ®Google Scholar
• Uemura, T., T. Goto, M.‑S. Kang, N. Mizoguchi, S. Hirai, J.‑Y. Lee, Y. Nakano, J. Shono, S. Hoshino, K. Taketani, et al. 2011. Diosgenin, the main aglycon of fenugreek, inhibits LXRα activity in HepG2 cells and decreases plasma and hepatic triglycerides in obese diabetic mice. The Journal of Nutrition 141(1):17–23.
   PubMed Web of Science ®Google Scholar
• Valeria D’Auria, M., V. Sepe, and A. Zampella. 2012. Natural ligands for nuclear receptors: Biology and potential therapeutic applications. Current Topics in Medicinal Chemistry 12(6):637–669.
   PubMed Web of Science ®Google Scholar
• Viennois, E., K. Mouzat, J. Dufour, L. Morel, J.-M. Lobaccaro, and S. Baron. 2012. Selective liver X receptor modulators (SLiMs): What use in human health? Molecular and Cellular Endocrinology 351(2):129–141.
   PubMed Web of Science ®Google Scholar
• Vincken, J.-P., L. Heng, A. de Groot, and H. Gruppen. 2007. Saponins, classification and occurrence in the plant kingdom. Phytochemistry 68(3):275–297.
   PubMed Web of Science ®Google Scholar
• Wallace, B. D., and M. R. Redinbo. 2013. Xenobiotic-sensing nuclear receptors involved in drug metabolism: A structural perspective. Drug Metabolism Reviews 45(1):79–100.
   PubMed Web of Science ®Google Scholar
• Wang, N., G. Zhao, Y. Zhang, X. Wang, L. Zhao, P. Xu, and D. Shou. 2017a. A network pharmacology approach to determine the active components and potential targets of Curculigo orchioides in the treatment of osteoporosis. Medical Science Monitor 23:5113–5122.
   PubMed Web of Science ®Google Scholar
• Wang, W., H. Wang, E. R. Rayburn, Y. Zhao, D. L. Hill, and R. Zhang. 2008. 20(S)-25-methoxyl-dammarane-3β, 12β, 20-triol, a novel natural product for prostate cancer therapy: Activity in vitro and in vivo and mechanisms of action. British Journal of Cancer 98(4):792–802.
   PubMed Web of Science ®Google Scholar
• Wang, X., Y. Wang, J.-P. Hu, S. Yu, B.-K. Li, Y. Cui, L. Ren, and L.-D. Zhang. 2017b. Astragaloside IV, a natural PPARγ agonist, reduces Aβ production in Alzheimer's disease through inhibition of BACE1. Molecular Neurobiology 54(4):2939–2949.
   PubMed Web of Science ®Google Scholar
• Wang, Z. Y., and D. W. Nixon. 2001. Licorice and cancer. Nutrition and Cancer 39(1):1–11.
   PubMed Web of Science ®Google Scholar
• Watkins, R. E., P. R. Davis-Searles, M. H. Lambert, and M. R. Redinbo. 2003. Coactivator binding promotes the specific interaction between ligand and the pregnane X receptor. Journal of Molecular Biology 331(4):815–828.
   PubMed Web of Science ®Google Scholar
• Wen, M., X. Li, L. Ai, M. Li, G. Du, and J. Zhao. 2011. Use of ginsenoside compound K in the preparation of a medicament for the prevention and treatment of atherosclerosis. US Patent App. No.: 13/125, 411, filed October 23, 2009 and issued September 1, 2011.
   Google Scholar
• Williams, S., R. K. Bledsoe, J. L. Collins, S. Boggs, M. H. Lambert, A. B. Miller, J. Moore, D. D. McKee, L. Moore, J. Nichols, et al. 2003. X-ray crystal structure of the liver X receptor β ligand binding domain: Regulation by a histidine-tryptophan switch. Journal of Biological Chemistry 278(29):27138–27143.
   PubMed Web of Science ®Google Scholar
• Wu, J., Z. Pan, Z. Wang, W. Zhu, Y. Shen, R. Cui, J. Lin, H. Yu, Q. Wang, J. Qian, et al. 2012. Ginsenoside Rg1 protection against β-amyloid peptide-induced neuronal apoptosis via estrogen receptor α and glucocorticoid receptor-dependent anti-protein nitration pathway. Neuropharmacology 63(3):349–361.
   PubMed Web of Science ®Google Scholar
• Xue, Y., E. Chao, W. J. Zuercher, T. M. Willson, J. L. Collins, and M. R. Redinbo. 2007. Crystal structure of the PXR-T1317 complex provides a scaffold to examine the potential for receptor antagonism. Bioorganic & Medicinal Chemistry 15(5):2156–2166.
   PubMed Web of Science ®Google Scholar
• Yan, X., Y. Fan, W. Wei, P. Wang, Q. Liu, Y. Wei, L. Zhang, G. Zhao, J. Yue, Z. Zhou, et al. 2014. Production of bioactive ginsenoside compound K in metabolically engineered yeast. Cell Research 24(6):770–773.
   PubMed Web of Science ®Google Scholar
• Yang, J., and P. J. Fuller. 2012. Interactions of the mineralocorticoid receptor-within and without. Molecular and Cellular Endocrinology 350(2):196–205.
   PubMed Web of Science ®Google Scholar
• Yang, J.-W., and S. Kim. 2015. Ginsenoside Rc promotes anti-adipogenic activity on 3T3-L1 adipocytes by down-regulating C/EBPα and PPARγ. Molecules 20(1):1293–1303.
   PubMed Web of Science ®Google Scholar
• Yu, J., M. Eto, M. Akishita, A. Kaneko, Y. Ouchi, and T. Okabe. 2007. Signaling pathway of nitric oxide production induced by ginsenoside Rb1 in human aortic endothelial cells: A possible involvement of androgen receptor. Biochemical and Biophysical Research Communications 353(3):764–769.
   PubMed Web of Science ®Google Scholar
• Zhang, J., L. Cao, H. Wang, X. Cheng, L. Wang, L. Zhu, T. Yan, Y. Xie, Y. Wu, M. Zhao., et al. 2015. Ginsenosides regulate PXR/NF-κB signaling and attenuate dextran sulfate sodium-induced colitis. Drug Metabolism and Disposition 43(8):1181–1189.
   PubMed Web of Science ®Google Scholar
• Zhang, J., T. Li, T. Wang, C. Yuan, S. Zhong, T. Guan, Z. Li, Y. Wang, H. Yu, Q. Luo, et al. 2018a. Estrogenicity of halogenated bisphenol A: In vitro and in silico investigations. Archives of Toxicology 92(3):1215–1223.
   PubMed Web of Science ®Google Scholar
• Zhang, J., T. Li, T. Wang, T. Guan, H. Yu, Z. Li., Y. Wang, Y. Wang, T. Zhang. 2018b. Binding interactions of halogenated bisphenol A with mouse PPARα: In vitro investigation and molecular dynamics simulation. Toxicology Letters 283:32–38.
   PubMed Web of Science ®Google Scholar
• Zhang, J., T. Zhang, T. Guan, H. Yu, and T. Li. 2017. In vitro and in silico assessment of the structure-dependent binding of bisphenol analogues to glucocorticoid receptor. Analytical and Bioanalytical Chemistry 409(8):2239–2246.
   PubMed Web of Science ®Google Scholar
• Zhang, J., T. Zhang, T. Guan, P. Ruan, D. Ren, W. Dai, H. Yu, and T. Li. 2017. Spectroscopic and molecular modeling approaches to investigate the interaction of bisphenol A, bisphenol F and their diglycidyl ethers with PPARα. Chemosphere 180:253–258.
   PubMed Web of Science ®Google Scholar
• Zhang, T., S. Zhong, L. Hou, T. Li, X. J. Xing, T. Guan, J. Zhang, and Y. Wang. 2018c. Estrogenic properties of coumarins and meroterpene from the fruits of Cullen corylifolium: Experimental and computational studies. Phytochemistry 152:148–153.
   PubMed Web of Science ®Google Scholar
• Zhang, T., S. Zhong, Y. Wang, S. Dong, T. Guan, L. Hou, X. J. Xing, J. Zhang, and T. Li. 2019. In vitro and in silico perspectives on estrogenicity of tanshinones from salvia miltiorrhiza. Food Chemistry 270:281–286.
   PubMed Web of Science ®Google Scholar
• Zhao, C., and K. Dahlman-Wright. 2010. Liver X receptor in cholesterol metabolism. The Journal of Endocrinology 204(3):233–240.
   PubMed Web of Science ®Google Scholar
• Zhao, D. 2016. Challenges associated with elucidating the mechanisms of the hypocholesterolaemic activity of saponins. Journal of Functional Foods 23:52–65.
   Web of Science ®Google Scholar
• Zhao, H. L., J. S. Sim, S. H. Shim, Y. W. Ha, S. S. Kang, and Y. S. Kim. 2005. Antiobese and hypolipidemic effects of platycodin saponins in diet-induced obese rats: Evidences for lipase inhibition and calorie intake restriction. International Journal of Obesity 29(8):983–990.
   Web of Science ®Google Scholar
• Zhao, H. L., K.-H. Cho, Y. W. Ha, T.-S. Jeong, W. S. Lee, and Y. S. Kim. 2006. Cholesterol-lowering effect of platycodin D in hypercholesterolemic ICR mice. European Journal of Pharmacology 537(1–3):166–173.
   PubMed Web of Science ®Google Scholar
• Zhu, B. T., G.-Z. Han, J.-Y. Shim, Y. Wen, and X.-R. Jiang. 2006. Quantitative structure-activity relationship of various endogenous estrogen metabolites for human estrogen receptor α and β subtypes: Insights into the structural determinants favoring a differential subtype binding. Endocrinology 147(9):4132–4150.
   PubMed Web of Science ®Google Scholar
• Zoete, V., A. Grosdidier, and O. Michielin. 2007. Peroxisome proliferator-activated receptor structures: Ligand specificity, molecular switch and interactions with regulators. BBA Molecular Cell Research 1771(8):915–925.
   PubMed Web of Science ®Google Scholar